| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |